Building effective strategies and plans can cause a business’ trajectory to boost. Only some people can develop a unique approach to overcome potential difficulties and make the system work in the long run. But there are strategists and consultants to provide some thoughtful ideas to grow your business. One of those exceptionally gifted professionals is Bill Garbarini, a US-based strategist who has helped numerous pharmaceutical companies overcome their problems and generate hefty revenue.
Recently, Bill was named founding COO of Conceivable Life Sciences, a startup company which hopes to make IVF more accessible to patients by introducing robotics and automation to the embryology laboratory. Conceivable is creating automation for the next generation of IVF, designing labs with the most advanced single cell robotics in the world. Conceivable’s labs hope to provide vastly more safety, efficiency, and scalability, so that everyone who needs IVF can access it.
Bill initiated his career as a Sales Representative, and since then, he has used his abilities to reach great heights. He never let the fear of the unknown baffle him and ultimately found his own consulting company Bold Move LLC. Before introducing his enterprise, he worked at a fertility tech company, TMRW Life Science, the world’s first and only automated platform for managing and caring for frozen embryos and eggs. This sparked his interest in the fertility industry. Alongside the consulting company, Bill plans on endorsing an IVF platform induced with the latest technology to take the initiative to a different height.
A business strategist’s essence isn’t solely about the plan or goal but about making critical decisions that enable you to serve your customers better. When this business giant made a choice, he did so outstandingly. Despite bold decisions, some CEOs knew Bill could achieve remarkable results for their companies. However, It was only through distinctive decisions that he realized he could produce exceptional outcomes and benefit the customers.
TMRW Life Sciences recruited Bill to change how frozen specimens were stored within the IVF clinic. Radio Frequency Identification was used to ensure the accurate transfer of vitrified embryos and oocytes by using the world’s first automated robotic storage platform. Bill also designed the first financial model, still used today, to ensure system compatibility within clinics. Over $175 million in equity capital was raised in Series A, B, and C rounds under his leadership. At TMRW Life Science, he led a significant transaction of $550 million valuation and created one of the world’s largest IVF networks, raising funds for IVF startups by building the world’s first automated robotic storage company for IVF materials.
Bill believes the development of AI and robotics, automation, and robotics for human health, are just a few of the many advances that can do wonders for the IVF industry. As a Vice President of Ferring Pharmaceuticals, he had responsibility for the company’s largest division, the Specialty Products Business Unit, where he assisted the company in growing by 58% on $100 million or more in annual revenue and contributed to several critical product initiatives.
Bill’s strategies extend far beyond the pharmaceutical industry because he focuses on improving IVF practice with increased care. Whether it’s business growth or goal setting, his approaches are universally applicable. To know more about Bill’s expertise, follow him on LinkedIn.
